Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes

NCT ID: NCT03015480

Last Updated: 2019-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-13

Study Completion Date

2018-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with diabetes and stage 1-3a CKD receive instructions on downloading and using MyFitnessPal on their smartphone or computer to log meal data daily, weekly website educational materials, and weekly telephone visits with a dietician for 8 weeks. Patients receive a follow-up phone call from the dietitian and 5 and 11 months for further support and counseling, and are also invited to attend a local dietitian-led grocery tour. This pilot study examines the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.

Main outcomes include sodium intake assessed by 24 hour urine collection as well as other dietary measures related to kidney disease (sodium/potassium ratio, Healthy Eating Index score, 24-hour urine phosphorus, estimated net endogenous acid production) and health measures (24-hour ambulatory blood pressure, weight, albumin/creatinine ratio)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Diabetes Mellitus Albuminuria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Remote counseling

This group of people will be asked to track dietary information on MyFitnessPal and receive remote dietary counseling with a dietitian.

Group Type EXPERIMENTAL

Remote counseling

Intervention Type BEHAVIORAL

For an 8 week period, patients will be asked to enter dietary information into the MyFitnessPal mobile application or website. Dietitians will access this information and provide personalized motivational interview phone calls on a weekly basis. After the initial 8 weeks, patients will receive a dietitian follow-up phone call around 5 and 11 months later.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote counseling

For an 8 week period, patients will be asked to enter dietary information into the MyFitnessPal mobile application or website. Dietitians will access this information and provide personalized motivational interview phone calls on a weekly basis. After the initial 8 weeks, patients will receive a dietitian follow-up phone call around 5 and 11 months later.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 21 years
* Diabetes diagnosis (Type I or Type II)
* Last urine albumin/creatinine ratio (ACR) within the past two years \> 30 mg/g
* Last outpatient estimated glomerular filtration rate (eGFR) within the past year \> 45 ml/min/1.73m2
* Last outpatient systolic blood pressure (SBP) within the past year \< 160 mmHg
* Last outpatient diastolic blood pressure (DBP) within the past year \<100 mmHg
* Preceding eGFR decline rate less than -2 ml/min/1.73m2/y
* At least 2 outpatient eGFR measurements in electronic health record, separated by at least 2 years
* Agreeable to change diet (decrease sodium and red/processed meat intake, increase fruit and vegetable intake)
* Access to smartphone or computer

Exclusion Criteria

* Inability to understand English
* Myocardial infarction, stroke, or atherosclerotic cardiovascular disease procedure within 6 months.
* Current treatment for malignancy
* Planned bariatric surgery
* Pregnancy or planning to become pregnant within next 2 years
* Self-reported average consumption of \> 14 alcoholic beverages per week
* Psychiatric hospitalization in past year
* Unstable angina
* Urine ACR \> 2500 mg/g
* Last potassium \> 5.0 mg/dL
* Hypoglycemia episode in past 1 month (glucose \< 70 mg/dL)
* Principal investigator discretion (i.e. concerns about safety, compliance)
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins University

OTHER

Sponsor Role collaborator

Geisinger Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alex Chang, MD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisinger Medical Center

Danville, Pennsylvania, United States

Site Status

Geisinger Wyoming Valley Medical Center

Wilkes-Barre, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Schrauben SJ, Inamdar A, Yule C, Kwiecien S, Krekel C, Collins C, Anderson C, Bailey-Davis L, Chang AR. Effects of Dietary App-Supported Tele-Counseling on Sodium Intake, Diet Quality, and Blood Pressure in Patients With Diabetes and Kidney Disease. J Ren Nutr. 2022 Jan;32(1):39-50. doi: 10.1053/j.jrn.2021.08.006. Epub 2021 Oct 11.

Reference Type DERIVED
PMID: 34649784 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-0382

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DIALYSIS-TIR Study
NCT06042153 ACTIVE_NOT_RECRUITING PHASE4
Renal Denervation in Diabetic Nephropathy
NCT01588795 COMPLETED PHASE4
Empagliflozin in ESKD - A Feasibility Study
NCT05687058 RECRUITING PHASE1/PHASE2